Tsung-Ying Yang

10PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersHaematological tumoursCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 06, 2026
Consensus recommendations for the management of Dato-DXd-associated adverse events in patients with advanced/metastatic NSCLC: insights from a multiregional steering committee.

|May 13, 2026
BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor Against Uncommon EGFR Mutations.

|Jul 13, 2024
Benefits of NGS in Advanced Lung Adenocarcinoma Vary by Populations and Timing of Examination.

Po-Hsin Lee, Wei-Fan Ou, Yen-Hsiang Huang

|Jan 11, 2024
Attenuation of PI3K-Akt-mTOR Pathway to Reduce Cancer Stemness on Chemoresistant Lung Cancer Cells by Shikonin and Synergy with BEZ235 Inhibitor.

Yen-Hsiang Huang, Ling-Yen Chiu, Jeng-Sen Tseng

|Jan 08, 2023
Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment.

Po-Hsin Lee, Yen-Hsiang Huang, Yu-Wei Hsu

|Jul 28, 2022
Curcumin Induces Apoptosis of Chemoresistant Lung Cancer Cells via ROS-Regulated p38 MAPK Phosphorylation.

Ming-Fang Wu, Yen-Hsiang Huang, Ling-Yen Chiu

Pageof 2

Frequent Collaborators

5 joint publications

Jeng-Sen Tseng

3 joint publications

Ho Lin

3 joint publications

Gee-Chen Chang

2 joint publications

Kun-Chieh Chen